...
首页> 外文期刊>AJRI: American Journal of Reproductive Immunology >Intravenous immunoglobulin treatment in women with recurrent abortions: increased cytokine levels and reduced Th1/Th2 lymphocyte ratio in peripheral blood.
【24h】

Intravenous immunoglobulin treatment in women with recurrent abortions: increased cytokine levels and reduced Th1/Th2 lymphocyte ratio in peripheral blood.

机译:反复流产妇女的静脉内免疫球蛋白治疗:增加外周血中细胞因子水平并降低Th1 / Th2淋巴细胞比率。

获取原文
获取原文并翻译 | 示例
           

摘要

PROBLEM: The aim of this study was to investigate changes in peripheral blood Th1/Th2 cytokine levels and lymphocyte ratios after massive intravenous immunoglobulin (MIVIg) treatment for women with recurrent spontaneous abortion (RSA) of unexplained etiology. METHOD OF STUDY: Serum Th1 (IFN-gamma, TNF-alpha) and Th2 cytokine (IL-4, IL-10) levels were assessed by ELISA methods (n = 9) and peripheral blood Th1/Th2 lymphocyte ratios (n = 4) by flow cytometry before and after MIVIg treatments in women with four or more consecutive RSA. RESULTS: Pre-treatment serum IFN-gamma (0.06 +/- 0.09 pg/mL, mean +/- SD), TNF-alpha (0.21 +/- 0.45 pg/mL), IL-4 (0.70 +/- 1.16 pg/mL), and IL-10 (1.12 +/- 1.67 pg/mL) increased to 0.17 +/- 0.16 pg/mL, 0.77 +/- 0.28 pg/mL, 1.82 +/- 0.89 pg/mL, and 3.44 +/- 0.48 pg/mL, respectively, after MIVIg treatments (P < 0.05). CD4-positive IFN-gamma/IL-4 lymphocyte ratios (17.3 +/- 9.1) were reduced to 11.5 +/- 7.1 after treatment (P < 0.05). CONCLUSIONS: Massive intravenous immunoglobulin treatments increased peripheral blood cytokine levels and decreased Th1/Th2 lymphocyte ratios; thus, MIVIg treatments modify the peripheral Th1/Th2 balance.
机译:问题:这项研究的目的是调查原因不明的反复自然流产(RSA)妇女大剂量静脉注射免疫球蛋白(MIVIg)治疗后外周血Th1 / Th2细胞因子水平和淋巴细胞比率的变化。研究方法:通过ELISA方法(n = 9)和外周血Th1 / Th2淋巴细胞比率(n = 4)评估血清Th1(IFN-γ,TNF-α)和Th2细胞因子(IL-4,IL-10)水平在具有四个或更多连续RSA的女性中,在MIVIg治疗之前和之后通过流式细胞术进行检测。结果:治疗前血清IFN-γ(0.06 +/- 0.09 pg / mL,平均值+/- SD),TNF-alpha(0.21 +/- 0.45 pg / mL),IL-4(0.70 +/- 1.16 pg / mL),而IL-10(1.12 +/- 1.67 pg / mL)增加到0.17 +/- 0.16 pg / mL,0.77 +/- 0.28 pg / mL,1.82 +/- 0.89 pg / mL和3.44 + MIVIg处理后分别为0.48 pg / mL(P <0.05)。治疗后CD4阳性IFN-γ/ IL-4淋巴细胞比率(17.3 +/- 9.1)降至11.5 +/- 7.1(P <0.05)。结论:大规模静脉注射免疫球蛋白治疗可增加外周血细胞因子水平并降低Th1 / Th2淋巴细胞比率。因此,MIVIg治疗改变了外周Th1 / Th2平衡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号